Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind placebo-controlled study of TM471-1 capsules in relapsing multiple sclerosis
CTR20261819Phase 2Active
- Sponsor
- Zhiwei Biopharma
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of TM471-1 in multiple sclerosis (MS), sponsored by Zhiwei Biopharma. Started May 2026; status: active.
02
Drugs
TM471-1
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20261819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261819.